ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding ProQR Therapeutics N.V. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 62 | 64 | +2 |
| Shares | 40.5M | 37.5M | −2.91M (−7.2%) |
| Value | $82.4M | $80.0M | −$2.41M (−2.9%) |
New holders (8)
Institutions that held ProQR Therapeutics N.V. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Palo Alto Investors LP | 188,807 | $402.2K | 0.07% |
| Quadrature Capital Ltd | 36,140 | $77.2K | 0.00% |
| Fifth Third Bancorp | 30,000 | $63.9K | 0.00% |
| Susquehanna International Group, LLP | 25,245 | $53.8K | 0.00% |
| Citigroup Inc | 22,724 | $48.4K | 0.00% |
| XTX Topco Ltd | 10,187 | $21.7K | 0.00% |
| Tower Research Capital LLC (TRC) | 893 | $1.90K | 0.00% |
| Rockefeller Capital Management L.P. | 34 | $72 | 0.00% |
Sold out (6)
Institutions that held ProQR Therapeutics N.V. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Vontobel Holding Ltd. | 63,979 | $130.5K |
| Bank of Montreal | 30,000 | $61.2K |
| HRT Financial LP | 12,297 | $25.0K |
| Engineers Gate Manager LP | 10,730 | $21.9K |
| Group One Trading, L.P. | 3,541 | $7.22K |
| Simplex Trading, LLC | 856 | $1.00K |